Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Speakers
The University of Texas MD Anderson Cancer Center
U.T. MD Anderson Cancer Center
Univ. Texas MD Anderson Cancer Center
Brody School of Medicine at ECU